Women outlive men almost everywhere, in nearly every era for which records exist. It is one of the most consistent findings in population health, and it has produced a comfortable assumption: that women are winning at longevity and the interesting problems lie elsewhere.
The healthspan data undoes that assumption in a specific and uncomfortable way.
The short version: women live longer than men and spend more of those years unwell. A 2024 analysis across 183 World Health Organization member states found the global gap between lifespan and healthspan was 9.6 years in 2019, with the United States highest in the world at 12.4 years. Women experienced a 2.4-year larger gap between lifespan and healthspan than men.¹ The years women gain are disproportionately years of managing disability or illness. That makes healthspan, not lifespan, the honest target for women's longevity, and it shifts the priority toward the things that preserve function: muscle, sleep, cardiometabolic health, and the years around menopause when the underlying trajectory is steepest.²
Lifespan is the wrong scoreboard
The distinction between lifespan and healthspan is not academic hair-splitting. It is the whole question.
Lifespan is how many years you live. Healthspan is how many of those years you live in good health, without significant disability or chronic disease burden. Our explainer on what healthspan actually means unpacks the definitions properly.
The global figures put the problem in view. Across 183 WHO member states, the average gap between the two was 9.6 years in 2019.¹ Nearly a decade, on average, lived in poor health at the end.
The United States had the largest gap in the world, with Americans living 12.4 years on average with disability and sickness.¹
And the sex difference is the finding that should reframe how women approach this: women's gap was 2.4 years larger than men's.¹
So the correct framing is not that women win at longevity. It is that women get more years and a larger share of those extra years are spent unwell. That is a different problem, and it points at different interventions.
Why the gap is larger for women
Several factors contribute, and no single one explains it.
Women live long enough to accumulate the conditions that arrive late: osteoporosis and fragility fracture, dementia, autoimmune disease, and the musculoskeletal conditions that limit function without shortening life. Many of these are disabling rather than fatal, which is precisely how a healthspan gap opens.
Women also experience a discrete biological event that men do not, and it lands in midlife rather than old age.
The menopause acceleration, and why it matters for longevity
This is the part most longevity content aimed at women skips, and it is arguably the most actionable.
In 2016, researchers analyzed epigenetic age acceleration across four large cohorts: the Women's Health Initiative (n = 1,864), Invecchiare nel Chianti (n = 200), the Parkinson's Disease, Environment, and Genes study (n = 256), and the UK Medical Research Council National Survey of Health and Development (n = 790).²
Increased epigenetic age acceleration in blood was significantly associated with earlier menopause. Bilateral oophorectomy, surgical removal of both ovaries, was associated with further acceleration. And Mendelian randomization supported menopause accelerating epigenetic aging rather than the reverse, which is a stronger causal claim than most biomarker research can make.²
Menopausal hormone therapy was associated with significantly lower epigenetic age acceleration in buccal epithelium.² That is one tissue and an association, not a trial of hormone therapy as a longevity intervention, and it should not be read as one.
The practical implication is about timing. If the underlying aging trajectory steepens during a defined window, the inputs during that window matter disproportionately. How women age differently at the cellular level covers the full mechanism.
What actually extends healthspan in women
Ranked by evidence, with what each does not establish held in the same view. That second column is the one most longevity content omits.
Intervention |
What the evidence supports |
What it does not establish |
|---|---|---|
Progressive resistance training |
Preserves lean mass through the window where it declines³ |
That it extends lifespan |
Adequate protein, distributed |
Supplies what muscle maintenance requires⁴ |
That extra protein builds muscle without training |
Sleep sufficiency |
Directly affects insulin sensitivity, with a larger effect in postmenopausal women⁵ |
That fixing sleep alone reverses metabolic risk |
Not smoking |
Associated with earlier menopause and accelerates most measured aging processes |
n/a, this one is unambiguous |
Treating menopause symptoms |
Makes every behavioral intervention achievable |
That hormone therapy is a longevity treatment |
Cardiometabolic screening |
Catches the conditions that create the disability years |
That screening alone changes outcomes without action |
Supplements matched to a measured need |
Correcting a real deficiency produces real benefit |
That any supplement extends human lifespan |
Muscle is the load-bearing intervention
If one item on that list determines whether your eighties are independent, it is lean mass.
Muscle underwrites walking speed, balance, glucose disposal, bone loading, and the ability to recover from an illness or a week in bed. It is also the tissue most directly affected by the menopause transition: across 1,246 women, lean mass shifted from roughly +0.2% per year premenopause to −0.2% per year during the transition, with both trajectories flattening about two years after the final period.³
That four-year window is when resistance training pays the most, because that is when the underlying trend is working against you.
Creatine deserves a specific note here because it is currently the most recommended supplement for women over 50, and it is being recommended for the wrong outcome. It has good evidence for muscle and strength alongside training. It does not improve bone density: a two-year randomized trial in 237 postmenopausal women found no effect on bone mineral density at the femoral neck, total hip, or lumbar spine.⁶ Choose it for muscle. Not for bone.
Sleep is a longevity intervention
The evidence here is stronger and more specific to women than most people realize.
In a randomized crossover trial, women who reduced sleep by about 90 minutes a night for six weeks, from 7.5 hours to 6.2, showed a 14.8% increase in insulin resistance. In postmenopausal participants the increase reached 20.1%, independent of changes in body fat.⁵
Ninety minutes, six weeks, a fifth of insulin sensitivity. Insulin resistance is upstream of a large share of the conditions that fill the healthspan gap.
Protein, at a level most women miss
The Menopause Society suggests about 1.2 grams of protein per kilogram of body weight daily at this stage, alongside at least 150 minutes of moderate aerobic activity weekly and strength training twice a week.⁷ Broader expert consensus places the range for older adults at roughly 1.0 to 1.2 g/kg, higher with illness or heavy training.⁴
Distribution matters as much as the total. Most people load two-thirds of their protein into dinner. Spreading a meaningful source across each meal gives muscle a stronger signal.
Where supplements honestly fit
Below all of the above, and narrower than the marketing.
No supplement has been shown to extend human lifespan. Some correct deficiencies, which produces real benefit when a deficiency exists. Some improve a specific functional outcome. Some move a biomarker, which is interesting and is not the same as improving health.
Two cautions specific to women over 50 are worth carrying. The US Preventive Services Task Force recommends against daily supplementation with 400 IU or less of vitamin D and 1,000 mg or less of calcium for primary fracture prevention in community-dwelling postmenopausal women, and found the evidence insufficient at higher doses.⁸ And a three-year randomized trial in adults aged 55 to 70 found that higher vitamin D doses produced lower radial bone density than 400 IU, in a dose-dependent pattern.⁹
More is not the strategy. Matched to a measured need is.
For category-level comparison, the 2026 longevity supplements guide and our running review of what is new and what actually works apply the same filter. For products specific to the menopause transition, best supplements for perimenopause weight gain and perimenopause supplements are the relevant guides. If you are evaluating NAD+ products, our NAD+ explainer covers where the evidence stops, and what anti-aging actually means is worth reading before buying anything sold on that language.
Fasting, mimetics, and the cellular pathways
Fasting activates nutrient-sensing and cellular repair pathways, including autophagy, which is why the category attracts serious research interest. The autophagy and fasting guide covers what happens across different windows.
For women specifically, the widely repeated warning that fasting disrupts female hormones is weaker than it sounds: a 12-month randomized trial found no change in testosterone, DHEA, SHBG, estradiol, estrone, or progesterone in premenopausal or postmenopausal women.¹⁰ Fasting and female hormones covers that literature, and does fasting help with perimenopause symptoms is honest about how little symptom evidence exists.
Mimio Biomimetic Cell Care is a daily fasting mimetic built around nicotinamide, spermidine, oleoylethanolamide, and palmitoylethanolamide at doses derived from research into a 36-hour human fast. What distinguishes it is that the finished formula was tested, not just its ingredients: a randomized controlled trial published in Scientific Reports enrolling adults averaging 62 years old, 47.6% female, overweight with elevated HbA1c, reporting better hunger control and reduced bloating and digestive discomfort over eight weeks alongside improvements in fasting glucose, total and LDL cholesterol, LDL particle number, and oxidized LDL.¹¹
It is a daily formula, not a longevity treatment and not menopause-specific. The trial did not measure lifespan and was not designed as a menopause study. The science page has the full detail, and what a fasting mimetic is covers the category.
What to actually do with this
The reframe is the point. If women already win on lifespan and lose on the years that follow, then optimizing for more years is solving the problem you do not have.
The target is function: staying strong enough, metabolically healthy enough, and independent enough that the last decade is not the one the statistics describe.
That points at a short list. Lift progressively, twice a week, permanently. Eat enough protein and spread it out. Sleep, and treat what is preventing it as a medical problem. Do not smoke. Screen for the cardiometabolic conditions that create disability years. Treat the menopause transition as the window where all of this pays the most, because the biology says it is.
Supplements can support that plan. Nothing on any shelf substitutes for it, and the products claiming otherwise are selling well ahead of their evidence.
Frequently asked questions
Why do women live longer than men but have worse health?
Women outlive men in nearly every population, but they spend more of those years in poor health. Globally the gap between lifespan and healthspan was 9.6 years in 2019, and women's gap was 2.4 years larger than men's.¹ Women live long enough to accumulate conditions that disable rather than kill, including osteoporosis, dementia, and autoimmune disease, and they experience menopause as a discrete midlife acceleration event.²
What is the healthspan-lifespan gap?
The difference between how long you live and how long you live in good health. Across 183 WHO member states the average was 9.6 years in 2019, with the United States highest in the world at 12.4 years.¹ It is a more useful target than lifespan because it describes quality rather than quantity of years.
Does menopause affect longevity?
It affects the aging trajectory measurably. Across four cohorts, earlier menopause was associated with greater epigenetic age acceleration, surgical removal of both ovaries was associated with further acceleration, and Mendelian randomization supported menopause as the cause rather than the consequence.² That does not mean menopause shortens life, and the practical implication is about the value of the inputs during that window.
What is the single most important thing women can do for longevity?
Progressive resistance training, if you have to pick one. Lean mass declines specifically during the menopause transition,³ and muscle underwrites walking speed, balance, glucose disposal, and the ability to recover from illness decades later. Protein and sleep make the training work.
Do longevity supplements work for women?
No supplement has been shown to extend human lifespan in anyone. Some correct deficiencies, which helps when a deficiency exists. Note two specific cautions for women over 50: the USPSTF recommends against routine low-dose vitamin D plus calcium supplementation for fracture prevention in community-dwelling postmenopausal women,⁸ and a three-year trial found higher vitamin D doses produced lower radial bone density than 400 IU.⁹
Is creatine good for women's bone health?
No, and this is a common error. Creatine has good evidence for muscle and strength alongside resistance training, but a two-year randomized trial in 237 postmenopausal women found no effect on bone mineral density.⁶ Take it for muscle if you are training. Do not take it expecting bone benefit.
How much protein do women over 50 need?
The Menopause Society suggests about 1.2 grams per kilogram of body weight daily at this stage.⁷ Broader consensus for older adults places the range at roughly 1.0 to 1.2 g/kg, higher with illness or heavy training.⁴ Distribution across meals matters as much as the daily total.
This article is educational and is not individual medical advice. Discuss hormone therapy, screening, supplements, and any fasting practice with a qualified healthcare professional, particularly if you have existing conditions or take medications.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
- Terzic A, Garmany A. Global healthspan-lifespan gaps among 183 World Health Organization member states. JAMA Netw Open. 2024. https://pubmed.ncbi.nlm.nih.gov/39661386/
- Levine ME, Lu AT, Chen BH, et al. Menopause accelerates biological aging. Proc Natl Acad Sci U S A. 2016;113(33):9327-9332. https://pubmed.ncbi.nlm.nih.gov/27457926/
- Greendale GA, Sternfeld B, Huang MH, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. https://insight.jci.org/articles/view/124865
- Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. https://pubmed.ncbi.nlm.nih.gov/23867520/
- Zuraikat FM, et al. Chronic insufficient sleep in women impairs insulin sensitivity independent of adiposity changes: results of a randomized trial. Diabetes Care. 2023. https://doi.org/10.2337/dc23-1156
- Chilibeck PD, Candow DG, Gordon JJ, et al. A 2-yr randomized controlled trial on creatine supplementation during exercise for postmenopausal bone health. Med Sci Sports Exerc. 2023;55(10):1750-1760. https://pubmed.ncbi.nlm.nih.gov/37144634/
- The Menopause Society. MenoNote: Midlife weight gain. https://menopause.org/wp-content/uploads/for-women/MenoNote-Weight-Gain.pdf
- US Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(15):1592-1599. https://pubmed.ncbi.nlm.nih.gov/29677309/
- Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK. Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial. JAMA. 2019;322(8):736-745. https://pubmed.ncbi.nlm.nih.gov/31454046/
- Lin S, Cienfuegos S, Ezpeleta M, Pavlou V, Runchey MC, Varady KA. Effect of time restricted eating versus daily calorie restriction on sex hormones in males and females with obesity. Eur J Clin Nutr. 2024;78(9):814-817. https://www.nature.com/articles/s41430-024-01461-5
- Rhodes CH, et al. A novel fasting mimetic (Mimio) creates fasting-like benefits to hunger control, oxidative stress, and cardiometabolic health in humans. Sci Rep. 2026;16:7812. https://www.nature.com/articles/s41598-026-38495-7

